FDA Inspection 1329542 — Carter BloodCare
The FDA completed an inspection of Carter BloodCare on Jul 21, 2026 in Plano, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 21, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Plano, TX (United States)